A Study in Healthy Subjects to Assess the Safety, Tolerability and Pharmacokinetics of HTL0022562
- First Posted Date
- 2021-06-28
- Last Posted Date
- 2025-02-20
- Lead Sponsor
- Nxera Pharma UK Limited
- Target Recruit Count
- 33
- Registration Number
- NCT04941989
- Locations
- 🇬🇧
Parexel Early Phase Clinical Unit, Harrow, Middlesex, United Kingdom
Comparison of Blood Levels of HTL0016878 From an Oral Capsule and an Oral Solution
Phase 1
Completed
- Conditions
- Healthy Subjects
- Interventions
- Drug: HTL0016878.Citrate Capsule 10 mgDrug: HTL0016878.HCl Solution 10 mg
- First Posted Date
- 2021-06-23
- Last Posted Date
- 2025-02-19
- Lead Sponsor
- Nxera Pharma UK Limited
- Target Recruit Count
- 15
- Registration Number
- NCT04935320
- Locations
- 🇬🇧
Hammersmith Medicines Research Ltd (HMR), London, United Kingdom
A Study in Healthy Subjects to Assess the Safety, Tolerability, PK and PD of HTL0030310
- First Posted Date
- 2019-02-20
- Last Posted Date
- 2025-02-19
- Lead Sponsor
- Nxera Pharma UK Limited
- Target Recruit Count
- 42
- Registration Number
- NCT03847207
- Locations
- 🇬🇧
Quotient Sciences, Nottingham, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath